title: [Consensus statement "Dementia 2010" of the Austrian Alzheimer Society].
abstract: The Austrian Alzheimer Society developed evidence-based guidelines based on a systematic literature search and criteria-guided assessment with subsequent transparent determination of grades of clinical recommendation. The authors evaluated currently available therapeutic approaches for the most common forms of dementia and focused on diagnosis and pharmacological intervention, taking into consideration the situation in Austria. The purpose of these guidelines is the rational and cost-effective use of diagnostic and therapeutic measures in dementing illnesses. Users are physicians and all other providers of care for patients with dementia in Austria.
authors.affiliation: Universitätsklinik für Neurologie, Medizinische Universität Graz, reinhold.schmidt@medunigraz.at
authors.forename: Reinhold
authors.initials: R
authors.lastname: Schmidt
authors.forename: Michael
authors.initials: M
authors.lastname: Marksteiner
authors.forename: Peter
authors.initials: P
authors.lastname: Dal-Bianco
authors.forename: G
authors.initials: G
authors.lastname: Ransmayr
authors.forename: C
authors.initials: C
authors.lastname: Bancher
authors.forename: T
authors.initials: T
authors.lastname: Benke
authors.forename: J
authors.initials: J
authors.lastname: Wancata
authors.forename: P
authors.initials: P
authors.lastname: Fischer
authors.forename: C F
authors.initials: CF
authors.lastname: Leblhuber
authors.forename: G
authors.initials: G
authors.lastname: Psota
authors.forename: M
authors.initials: M
authors.lastname: Ackerl
authors.forename: C
authors.initials: C
authors.lastname: Alf
authors.forename: K
authors.initials: K
authors.lastname: Berek
authors.forename: A
authors.initials: A
authors.lastname: Croy
authors.forename: M
authors.initials: M
authors.lastname: Delazer
authors.forename: P
authors.initials: P
authors.lastname: Fasching
authors.forename: T
authors.initials: T
authors.lastname: Frühwald
authors.forename: G
authors.initials: G
authors.lastname: Fruhwürth
authors.forename: B
authors.initials: B
authors.lastname: Fuchs-Nieder
authors.forename: G
authors.initials: G
authors.lastname: Gatterer
authors.forename: J
authors.initials: J
authors.lastname: Grossmann
authors.forename: H
authors.initials: H
authors.lastname: Hinterhuber
authors.forename: B
authors.initials: B
authors.lastname: Iglseder
authors.forename: D
authors.initials: D
authors.lastname: Imarhiagbe
authors.forename: C
authors.initials: C
authors.lastname: Jagsch
authors.forename: K
authors.initials: K
authors.lastname: Jellinger
authors.forename: M
authors.initials: M
authors.lastname: Kalousek
authors.forename: P
authors.initials: P
authors.lastname: Kapeller
authors.forename: G
authors.initials: G
authors.lastname: Ladurner
authors.forename: C
authors.initials: C
authors.lastname: Lampl
authors.forename: A
authors.initials: A
authors.lastname: Lechner
authors.forename: A
authors.initials: A
authors.lastname: Lingg
authors.forename: T
authors.initials: T
authors.lastname: Nakajima
authors.forename: M
authors.initials: M
authors.lastname: Rainer
authors.forename: F
authors.initials: F
authors.lastname: Reisecker
authors.forename: J
authors.initials: J
authors.lastname: Spatt
authors.forename: T
authors.initials: T
authors.lastname: Walch
authors.forename: M
authors.initials: M
authors.lastname: Uranüs
authors.forename: A
authors.initials: A
authors.lastname: Walter
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000596:Amino Acids / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D003072:Cognition Disorders / Q000175:diagnosis / Q000188:drug therapy; D003430:Cross-Sectional Studies; D003704:Dementia / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005260:Female; D020441:Ginkgo biloba; D006801:Humans; D015994:Incidence; D008019:Life Style; D008134:Long-Term Care; D008297:Male; D055118:Medication Adherence; D008559:Memantine / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D018697:Nootropic Agents / Q000627:therapeutic use*; D010936:Plant Extracts / Q000009:adverse effects / Q000627:therapeutic use; D011157:Population Dynamics; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
chemical_list: D000596:Amino Acids; D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D018697:Nootropic Agents; D010936:Plant Extracts; D011619:Psychotropic Drugs; C006952:cerebrolysin; D008559:Memantine